Mount Yale Investment Advisors LLC Sells 3,730 Shares of CVS Health Co. (NYSE:CVS)

Mount Yale Investment Advisors LLC decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 3.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 105,308 shares of the pharmacy operator’s stock after selling 3,730 shares during the period. Mount Yale Investment Advisors LLC’s holdings in CVS Health were worth $6,219,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CVS. Wedmont Private Capital increased its holdings in CVS Health by 0.8% during the 1st quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock worth $1,410,000 after purchasing an additional 146 shares in the last quarter. Moody National Bank Trust Division grew its holdings in shares of CVS Health by 0.7% during the first quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock worth $1,776,000 after buying an additional 150 shares in the last quarter. Landmark Financial Advisors LLC raised its position in CVS Health by 3.8% in the 4th quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock valued at $329,000 after buying an additional 153 shares during the last quarter. Garland Capital Management Inc. lifted its stake in CVS Health by 0.3% in the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock valued at $3,591,000 after acquiring an additional 160 shares in the last quarter. Finally, Sepio Capital LP raised its holdings in shares of CVS Health by 1.7% in the fourth quarter. Sepio Capital LP now owns 9,907 shares of the pharmacy operator’s stock valued at $782,000 after purchasing an additional 163 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently weighed in on CVS shares. Evercore ISI decreased their target price on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Robert W. Baird started coverage on CVS Health in a research report on Thursday, May 30th. They issued a “neutral” rating and a $61.00 target price on the stock. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research note on Wednesday, September 4th. Baird R W upgraded CVS Health to a “hold” rating in a research note on Thursday, May 30th. Finally, JPMorgan Chase & Co. decreased their target price on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Eleven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $72.10.

CVS Health Trading Down 1.5 %

Shares of CVS stock opened at $57.51 on Friday. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a market capitalization of $72.20 billion, a PE ratio of 10.11, a price-to-earnings-growth ratio of 0.79 and a beta of 0.53. The firm has a 50 day moving average price of $58.31 and a two-hundred day moving average price of $62.52. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. During the same period last year, the firm posted $2.21 EPS. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, analysts predict that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.63%. The ex-dividend date is Monday, October 21st. CVS Health’s dividend payout ratio is 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.